|
|
|
|
|
|
by JumpCrisscross
2 hours ago
|
|
|
> Third party private healthcare decisions are almost non-existant in the US due to the payment systems The payment part is almost entirely pushing against GLP-1 agonists. Nobody has a long-term financial stake in patient costs to care that lifetime costs will likely be lower; insurers are just looking at the next couple years against expected churn. Another cost of tying health insurance to employment. |
|
|